Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 3, 2025, while a date of March 25, 2025, has been removed.SummaryDifference0.6%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.